A round up of genomics research is presented in this Telegraph anthology of recent articles from international news sources. Millions of dollars are being funneled into a project to "unlock"  DNA, personal genomics could become second nature, and challenges that have held up the science of genomics and its applications are presented.

The FDA has announced that more than 11,000 lab-driven diagnostic tests that have never been regulated will now fall under the agency's oversight. This includes cancer screening and genetic testing, an area of research that has exploded in the past couple of decades.

The University of California San Francisco is creating a magical new world of woodland forests and cable cars in a family friendly molecular imaging and radiology suite, reports SF Gate. 

Nematode worms are providing a very, very small window on the neural connections that we humans share. A feature in New Scientist follows the circuitous path of our knowledge about consciousness and the neural networks of the brain.

A feature in The New Yorker explores how Daniela Schiller, PhD, from the Mount Sinai School of Medicine’s Brain Imaging Core in New York City, has approached a kind of memory erasure for people who have suffered greatly from post-traumatic stress disorder (PTSD) with the aid of cutting-edge neuroimaging.

A cutting-edge detector developed by researchers in the United Kingdom and South Africa stands to spark more effective proton therapy for cancer patients.

The Alzheimer's Association International Conference is schedule to be held July 12-17 at the Bella Center in Copenhagen, Denmark. The meeting will feature many scientific sessions, plenary sessions and symposia dedicated to the most up-to-date Alzheimer's disease research.

The 19th world congress on heart disease organized by the International Academy of Cardiology will be covering the cutting edge of cardiovascular research, including molecular and cellular cardiology, from July 25-28 at the Hyatt Regency Boston.

Wednesday is the last day of the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting in St. Louis, but the news and images keep coming.

ST. LOUIS--As the weekend opening of the 61st Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting sunsets, three more days full of meetings, presentations and exhibitions approach. See an SNMMI-hosted audiovisual montage of highlights and attendee interviews from the first two days of the conference.

The new cancer center paradigm provides genetic tests not just for experimental research, but as a clinical standard. In this glimpse by Bloomberg, Memorial Sloan Kettering Cancer Center shows off a new laboratory opened just weeks ago where patients' biopsies will be tested for 341 mutations associated with disease.

T cell immunotherapy prompted a striking response from three out of nine women with advanced cervical cancer, including one who had extensive metastases, according to new data from the National Cancer Institute. This could offer an alternative treatment option for women with few choices remaining.